Equity
€34,884 from €100,865 in 2024
Equity fell by 65% in 1 year.
CD MED
Lifetime
14 annual accounts with figures on one time axispeak €94,000 (2021)
€4,860▼ 92.6%
lowest -€22,781 (2025)
-€22,781▼ €48,417
peak €100,865 (2024)
€34,884▼ 65.4%
€173,876▲ 7.4%
Board1 name since 2011
-
Documentsfilings and deeds
16-07-202615 days before the deadline
2025micro format
Gross margin from €65,292 to €4,860Loss of €22,781Dividend €43,200Equity from €100,865 to €34,884Cash from €20,394 to €0
Key points
from the 2025 annual accountsChecked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 1,294 companies had the same profile as CD MED has now. Each dot stands for 4 companies, two years later.
89.6%
were still trading
5.9%
stopped another way
4.1%
went bankrupt
Another 0.5% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 1,294 companies, not a prediction for CD MED. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0836613617
Change of role: , from statutory manager to director
Permanent representative: · Director discharge: · General meeting of 27-03-2024 · Gazette deed
Incorporation
published on 14-06-2011 · Gazette deed
First establishment
Rue du Tumulus (Piét.) 32, Jodoigne
Official details
Source: KBO- Status
- Active since 25-05-2011Normal situation
- Activity
- “L'exercice de la Médecine au sens général,et en particulier l’exercice de la médecine générale,en…” (deed in French)From the articles, 4 activitiesNo NACE code in the KBO yet
- Establishment unit
- 2.201.243.6651370 Jodoigne, since 25-05-2011
- Financial year end
- 31 December
- Peppol
- Reachable since 19-10-2025
Annual accounts 2025
- ≈ €36,000estimated
- €208,760▼ 20.6%
- Filing
- Filed on 16-07-2026, 15 days before the end of the filing period
Insights on CD MED
CD MED files the micro format. That format states no turnover. The gross margin fell from €91,571 in 2012 to €4,860 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about CD MED
- What is the company number of CD MED?
- The company number of CD MED is 0836.613.617. The VAT number is the same number with BE in front: BE 0836.613.617.
- Where is CD MED based?
- The registered office is at Rue du Tumulus (Piét.) 32, 1370 Jodoigne.Company details
- What is the legal form of CD MED?
- CD MED is a private limited company (BV).
- When was CD MED founded?
- CD MED was founded on 25-05-2011.
- Is CD MED still active?
- Yes, CD MED is an active enterprise in the KBO register.
- How many employees does CD MED have?
- CD MED had an average of 0.4 full-time equivalents in financial year 2023, according to the filed annual accounts.Financials
- What is the turnover of CD MED?
- The turnover in financial year 2025 is ≈ €36,000. This figure is estimated from the gross margin of €4,860 and 7,098 comparable companies of the same size. It probably lies between €16,000 and €86,000. It is a rough estimate. In financial year 2022 turnover was €110,672.
- Is CD MED profitable?
- In financial year 2025, CD MED made a loss of €22,781.
- Where can I find the annual accounts of CD MED?
- CD MED filed 14 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of CD MED due?
- CD MED must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.